Hypergrowth Investing
蜜桃传媒 360
Smart Money
InvestorPlace Digest
Latest Research
Stay up to date with the latest insights and market analysis from our top editors.
AI Is Coming for a Surprising Industry
For pharma companies, the soaring price of drug development comes with real costs. In fact, the situation is so bad that researchers have taken to calling this phenomenon “Eroom’s Law.” That’s “Moore’s” spelled backward. However, upcoming technological advancements could change Eroom's backwards fate… and, therefore, boost healthcare-related plays.
Meet the Experts
At Investorplace we pride ourselves on picking the best and brightest analysts.
Each is an expert in their respective field.
Luke Lango
InvestorPlace Senior Investment Analyst
Luke Lango is a growth-focused equities investor and analyst. He has developed a strong reputation for leaning into his tech background and “big-picture” investment philosophy to regularly identify next-generation, small-cap stocks and cryptocurrencies with huge upside potential.
Current Services:
Louis Navellier
Editor, Growth Investor
Louis Navellier is one of Wall Street’s renowned growth investors. Providing investment advice to tens of thousands of investors for more than three decades, he has earned a reputation as a savvy stock picker and unrivaled portfolio manager.
Current Services:
Eric Fry
Editor, Fry’s Investment Report
Eric J. Fry has been a specialist in international equities for nearly two decades. He was a professional portfolio manager for more than 10 years, specializing in international investment strategies and short-selling.
Current Services:
